Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Pharma Guide

To find a commercial service, choose an option from the Main Category below or Search by Company Name.

Approvals Action
Janssen's new biologic approved
Will challenge Humira for lucrative psoriasis market, plus new indication for Novartis drug.
Pipeline Monitor
Keytruda chases 14th indication
Cervical cancer next on the IO blockbuster's list.
What's behind MA's CEO problem?
Board needs to ask questions over vanishing secretariat leaders.